Glaxo Group Research

GSK is a global biopharmaceutical company focused on uniting science, technology, and talent to get ahead of disease together. The company prioritizes innovation in vaccines and specialty medicines, particularly in the areas of infectious diseases, HIV, oncology, and respiratory immunology. GSK's research strategy is driven by a focus on the immune system, human genetics, and advanced technologies such as functional genomics and artificial intelligence. With a portfolio that includes market-leading products like Shingrix and Arexvy, GSK aims to deliver high-impact medicines that prevent and treat disease on a global scale. The company operates significant R&D and manufacturing facilities worldwide, maintaining a strong commitment to sustainable health impact.